Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
2.260
-0.100 (-4.23%)
Jun 3, 2026, 10:51 AM EDT - Market open
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $3.23 million as of June 3, 2026. Its market cap has decreased by -37.90% in one year.
Market Cap
3.23M
Enterprise Value
-1.21M
1-Year Change
-37.90%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.33M to $3.23M, a decrease of -87.74%. That is a compound annual growth rate of -23.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 3.37M | -42.52% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.55M | 131.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 4.45M |
| Decoy Therapeutics | 4.45M |
| CDT Equity | 4.35M |
| Revelation Biosciences | 4.26M |
| 60 Degrees Pharmaceuticals | 3.88M |
| VivoSim Labs | 3.73M |
| Azitra | 3.63M |
| Virax Biolabs Group | 3.56M |